The Apple Watch’s new hypertension notification feature, designed to alert users to potential high blood pressure, isn’t a foolproof solution for identifying everyone with the condition. A recent study published February 9 in the Journal of the American Medical Association reveals that while the feature can successfully flag some individuals with undiagnosed hypertension, a significant portion may not receive any notification at all. This raises questions about the reliance on consumer wearables for population-wide health screening.
The Apple Watch utilizes photoplethysmography – a non-invasive optical technique that measures blood volume changes using light – to estimate blood pressure trends. Cleared by the US Food and Drug Administration in September 2025, the feature aims to proactively identify potential health issues without requiring a traditional blood pressure cuff . But, researchers are now examining the feature’s real-world effectiveness and potential limitations.
The study, led by Jordana B. Cohen, M.D., from the Perelman School of Medicine at the University of Pennsylvania, analyzed data from the National Health and Nutrition Examination Survey (NHANES) spanning 2017 to 2020. Researchers assessed the positive and negative predictive values of the Apple Watch’s hypertension notification. They found a positive predictive value of 69.1 percent and a negative predictive value of 79.0 percent. This means that roughly 69 out of 100 people who receive a hypertension notification from their Apple Watch may actually have high blood pressure, while approximately 79 out of 100 people who don’t receive a notification are likely to have normal blood pressure.
The effectiveness of the notification varied significantly by age group. For individuals under 30, an alert increased the probability of hypertension from 0.14 to 0.47. However, for those 60 and older, the probability jumped from 0.45 to 0.81 with an alert. Conversely, without an alert, the probability decreased to 0.10 for younger adults and 0.34 for older adults. These findings suggest the Apple Watch’s algorithm may be more reliable in detecting hypertension in older populations.
False Reassurance and Missed Opportunities
A key concern highlighted by the study authors is the potential for “false reassurance.” The research indicates that a substantial number of individuals with undiagnosed hypertension may not receive an alert from their Apple Watch, potentially leading them to believe their blood pressure is normal. This could discourage them from seeking proper medical screening and treatment, resulting in delayed diagnosis and management of a serious health condition. As the authors wrote, “an even larger proportion of individuals with undiagnosed hypertension could receive no alert at all.”
The Apple Watch is the most widely adopted consumer health device globally, with over 200 million users worldwide . The FDA clearance of the Hypertension Notification Feature represents a significant step in digital health, offering new avenues for identifying individuals who may benefit from early intervention. However, the study underscores the importance of interpreting these notifications cautiously and not relying solely on the device for accurate blood pressure assessment.
Researchers from the University of Utah and the University of Pennsylvania collaborated on this analysis, further validating the findings . The study builds on previous research exploring the potential of cuffless blood pressure devices to revolutionize hypertension screening and management .
What’s Next for Wearable Hypertension Detection?
While the Apple Watch’s hypertension notification feature shows promise in identifying some individuals with undiagnosed hypertension, it’s not a substitute for regular medical checkups and validated blood pressure measurements. Further research is needed to refine the algorithms and improve the accuracy of these wearable devices, particularly in diverse populations. The ongoing evaluation of these technologies will be crucial in determining their role in population health screening and preventative care. As of February 20, 2026, studies continue to assess the feature’s long-term impact and potential for integration into clinical practice .
What are your thoughts on using wearable technology for health monitoring? Share your comments below, and let’s continue the conversation.
